JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 1, 2002, Pages 3-10

  Finch, J ^a   Joseloff, E ^b   Bowden, G ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b CELERA GENOMICS   (United States)

Author keywords

AP 1 transactivation; Cell proliferation; Squamous cell carcinoma

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC TRANSFECTION; KERATINOCYTE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN CARCINOMA; TRANSACTIVATION; TUMOR XENOGRAFT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; ELECTROPORATION; GENE EXPRESSION REGULATION; KERATINOCYTES; KINETICS; MICE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-JUN; RECOMBINANT PROTEINS; SKIN NEOPLASMS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

EID: 0036174866     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-001-0298-x     Document Type: Article

References (39)

1. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
2. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo
3. APl/jun function is differentially induced in promotion-sensitive and resistant JB6 cells
4. Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells
5. Overexpression of c-Jun, JunB, or junD affects cell growth differently
6. Jun-B oncogene aberrations in cervical cancer cell lines
7. Expression of the jun-B gene during induction of monocytic differentiation
8. Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice
9. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells
10. Progressive elevation of AP-1 activity during preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants
11. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes
12. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin
13. Okadaic acid induces transcription of JunB through a CCAAT Box and NF-Y
14. Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinocytes
15. Okadaic acid induces the expression of both early and secondary response genes in mouse keratinocytes
16. Ultraviolet B-induced activated protein-1 activation does not require epidermal growth factor receptor but is blocked by a dominant negative PKClambda/iota
17. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid
18. AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells
19. Regulation of the transcription factor AP-1 in benign and malignant mouse keratinocyte cells
20. AP-1 function and regulation
21. Efficient gene expression in mamalian cells from a dicistronic transcriptional unit in an improved retroviral vector
22. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation
23. Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1. Jun-B and histone variants
24. Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium
25. JunB suppresses cell proliferation by transcriptional activation of pl6(INK4a) expression
26. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage
27. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras
28. Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation
29. Okadaic acid stimulated TRE binding activity in a papilloma producing mouse keratinocyte cell line involves increased AP-1 expression
30. A gene activated by growth factors is related to the oncogene v-jun
31. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: Effect of FOS proteins
32. c-fos is required for malignant progression of skin tumors
33. Opposite functions of jun-B and c-jun in growth regulation and neuronal differentiation
34. jun-B inhibits and c-fos stimulates the transforming and transactivating activities of c-jun
35. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts
36. Neoplastic transformation of rat thyroid cells requires the JunB and fra-1 gene induction which is dependent on the HMGI-C gene product
37. Increased transforming activity of JunB and JunD by introduction of an heterologous homodimerization domain
38. c-jun and multistage carcinogenesis: Association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation
39. Transgenic mice demonstrate AP-1 (activator protein-l) transactivation is required for tumor promotion